AARD

Aardvark Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

6.0%

Short % Float

4.5d to cover · Moderate squeeze

52.6%

Inst % Float

10 holders · 2026-06-30

Decheng Capital LL

Top Holder

17.9% of float

10.9M sh

Public Float

36/100

Dilution Score

Medium

20 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

36/100

MEDIUM

Inst: 52.62% · Top: Decheng Capital LLC

Biotech Analytics

Biotech / Pharma

8.31

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk36

Clinical Trials0

Short Interest30